Loading clinical trials...
Loading clinical trials...
This is an 'N of 1', open-label, single center study to evaluate the safety of therapy with VCA-894A, an ASO designed to rescue and restore the activity of IGHMBP2, when administered by intrathecal in...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vanda Pharmaceuticals
NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more
NCT07021638 · Home-based Programs, EzyGain, and more
NCT07136844 · Neuromuscular Diseases, Obesity (Disorder), and more
NCT06573866 · Parkinson Disease, Hereditary Spastic Paraparesis, and more
NCT06708468 · Neuromuscular Diseases (NMD), Charcot Marie Tooth Disease (CMT), and more
Vanda Investigational Site
Madison, Wisconsin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions